US FDA reveals plans for single cancer drug regulation centre Scheme is part of US government Cancer Moonshot initiative
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Brexit: could European Medicines Agency stay in London? Pharma wants single regulatory system to remain.
News EU regulator wants more advanced therapies Only a handful of products have reached the market in eight years.
News FDA asks for more data on Sarepta's muscular dystrophy drug Regulator asks for more data from ongoing trial.
Cancer Novartis' Afinitor gets new EU cancer use Novartis’ Afinitor has been approved in a new cancer indication in Europe – but faces potential competition from newer drugs.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
